All News

COVID infection mask

Combo Anti-Spike Protein Antibody for Mild to Moderate COVID-19

Jack Cush, MD

JAMA has published the BLAZE-1 study, showing significant SARS-CoV-2 viral load reduction at day 11 and less COVID-19 progression when combination anti-spike monoclonal antibody therapy (bamlanivimab and etesevimab) was given to mild to moderate, non-hospitalized COVID-19 patients.

Read Article
Telemedicine black computer

Inequities in Telemedicine During COVID-19

MedPage Today

Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began. The Federal Communications Commission estimates that about 21 million Americans don't have access to the Internet in their homes. Other sources estimate it is closer to 162 million.

Read Article
travel3.jpg

Travel During COVID-19 Pandemic

Jack Cush, MD

The CDC has addressed the effects and the issues of domestic and international travel on its website.  Below is a sampling of key advice.

Read Article
2020 Year Review

2020 Rheumatology Year in Review

Jack Cush, MD

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related.

Read Article
FINAL 2020 Podcast Graphic

RheumNow Podcast – Lights, Camera, Zoom (1.8.2021)

Jack Cush, MD

Dr. Jack Cush reviews the news, journal articles and favorite blogs from this past week on RheumNow.com.

Read Article
Toci led to poorer outcomes in this study. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial | The BMJ https://t.co/95zaq2CEUU

Links:

Dr Philip Robinson philipcrobinson ( View Tweet)

Inequities in Telemedicine During COVID-19 Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began but what if you don't have access to reliable technology? The problem spreads beyond that though. https://t.co/L8nvUbOqHA https://t.co/SZSmerQGEY

Links:

Dr. John Cush RheumNow ( View Tweet)
Travel During COVID-19 Pandemic--The CDC has addressed the effects and the issues of domestic and international travel on its website. Read the full article for more information. https://t.co/wtn5dV6swM https://t.co/0HdC5CfUop

Links:

Dr. John Cush RheumNow ( View Tweet)
New QD Clinic—This week’s videos: Clinic Emergencies, Stopping Meds, 3 Issues After COVID Vaccination, My New Clinic COVID Routine, Raynaud's or Not https://t.co/R0zcRq6Sg1

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast Now UP – Steroids, IVIG & the Vaccine. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more... https://t.co/f0wWTm2kV5

Links:

Dr. John Cush RheumNow ( View Tweet)

New Download Available on COVID-19 & mRNA Vaccines https://t.co/mvmn17Fl3B https://t.co/ceICzbDZi5

Links:

Dr. John Cush RheumNow ( View Tweet)
QD Clinic - What to do After COVID Vaccination https://t.co/25RcMOdAkK https://t.co/EWnYJGNqvY

Links:

Dr. John Cush RheumNow ( View Tweet)
Hydroxychloroquine Shortage During COVID-19--According to a recent report in Annals of Rheumatic Disease, public enthusiasm for hydroxychloroquine (HCQ) created significant access issues for rheumatic patients in the early phases of the COVID-19 pandemic. https://t.co/h9hrAfv9xo https://t.co/IVSYCueK2h

Links:

Dr. John Cush RheumNow ( View Tweet)
National Psoriasis Foundation Task Force updated their COVID-19 guidance statements. Including Guidance 4.6, stating PsA pts who receive a mRNA-COVID vaccine should continue their biologic or oral therapies as they manag of their psoriatic disease https://t.co/byujtDET33

Links:

Dr. John Cush RheumNow ( View Tweet)

After your 2 doses of COVID vaccine, YES you need to continue to wear a mask, cont. hand washing & social distancing - so as to continue to protect yourself and others. While vaccinated you can still become infected and spread infection. https://t.co/TkcSNx0hF1

Links:

Dr. John Cush RheumNow ( View Tweet)

A oatint infected with COVID-19- Yes they should get vaccinated ~90days after infection has resolved.Antibody testing is not needed before you are vaccinated. Evidence suggests that reinfection is uncommon in the 90 days after initial infection. https://t.co/TkcSNx0hF1.

Links:

Dr. John Cush RheumNow ( View Tweet)

Preprint results of the REMAP-CAP trial in the UK shows that IL-6 inhibitors, when given within 24 hrs of ICU entry for COVID-19, lowers mortality rate by 36%. Hosp mortality in 353 TCZ was 28%, 48 sarilumab was 22% in 402 controls was 36%. https://t.co/fkjOz99t0l

Links:

Dr. John Cush RheumNow ( View Tweet)

ACR Convergence 2020 Late Breaking Abstracts available from the ACR "Spotlight" slide give away. 10 slides on COVID, Tyk2 in PsA, FAST febuxostat study, Tofa in AS and novel drugs for SLE and PSS https://t.co/DvcDyusCUR

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast is up! Benlysta safety, HCQ lowers thromboses, HCQ adherence, Telemedicine, Actemra in COVID,, 2021 looking forward and zoomatology! Watch it here>> https://t.co/PtfEUPB1hc or listen to podcast on Apple> https://t.co/FHJv01AAbC or Android>https://t.co/Iylluqqeej

Links:

Dr. John Cush RheumNow ( View Tweet)

Head to RheumNow for our latest Covid-19 articles. https://t.co/TiB7739ONL

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×